JPRN-jRCT2080221169未知3 期
ong-term study on combinational therapy of SMP-508 with pioglitazone in patients with type 2 diabetes mellitus
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with type 2 diabetes mellitus who participated in the previous study Phase 3 study on combinational therapy of SMP-508 with pioglitazone in patients with type 2 diabetes mellitus, and meet all of the following requirements.
- •-Patients who underwent the surveys, observations, and tests, etc. scheduled to be conducted in week 16 of the previous study.
- •-Patients who, prior to admission to the study, voluntarily agree to participate in the study after receiving an explanation of the study objectives, methods, and potential risks.
- •-Patients who provide written informed consent.
排除标准
- •-Women who are pregnant or have a potential of pregnancy during the study, women who are at risk of pregnancy due to lack of appropriate contraceptive measures, and lactating mothers
- •-Patients who will require surgery.
- •-Patients whom the investigator or subinvestigator considers to be unsuitable for administration to the study for any other reason.
研究者
相似试验
未知
3 期
ong-term study on combinational therapy of SMP-508 with dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitusJPRN-jRCT2080221738Sumitomo Dainippon Pharma Co.,Ltd.80
未知
3 期
ong-term study on combinational therapy of SMP-508 with metformin in patients with type 2 diabetes mellitusType 2 diabetes mellitus whose blood glucose levels are not adequately controlled by metformin in addition to diet and exercise therapiesJPRN-jRCT2080221167Dainippon Sumitomo Pharma Co., Ltd.120
未知
3 期
Phase 3 study on combinational therapy of SMP-508 with metformin in patients with type 2 diabetes mellitusJPRN-jRCT2080221166Dainippon Sumitomo Pharma Co., Ltd.120
未知
3 期
Phase 3 study on combinational therapy of SMP-508 with pioglitazone in patients with type 2 diabetes mellitusType 2 diabetes mellitus patients whose blood glucose levels are not adequately controlled by pioglitazone in addition to diet and exercise therapiesJPRN-jRCT2080221168Dainippon Sumitomo Pharma Co., Ltd.120
已完成
3 期
Efficacy of Pentoxifylline in diabetic nephropathyCondition 1: Type 2 Diabetes. Condition 2: Diabetic Nephropathy.Type 2 diabetes mellitus????????? ????????N00-N08IRCT20190806044451N2Zanjan University of Medical Sciences60